Compare Check Point Software Technologies Ltd (CHKP) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Check Point Software Technologies Ltd vs Novartis AG — how do they compare? Check Point Software Technologies Ltd trades at $129.01 (market cap $13.18B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 22.4× Check Point Software Technologies Ltd's market cap, and Novartis AG pays a 3.07% dividend while Check Point Software Technologies Ltd pays none. Which is the better fit depends on your goals.
| CHKP | NVS | |
|---|---|---|
Market Cap | $13.18B | $295.37B |
Sector | Technology | Health |
52-Week High | $206.91 | $168.62 |
52-Week Low | $112.47 | $119.31 |
Enterprise Value | $12.88B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Check Point Software Technologies Ltd
Check Point is a global leader in cybersecurity solutions. It provides comprehensive protection against advanced cyber threats for corporate networks, cloud environments, mobile devices, and critical infrastructure.
Read more on CHKP →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
